Literature DB >> 23401218

L-dopa treatment duration versus Parkinson's disease progression: the dorsal-ventral divide.

Pauline Belujon, Anthony A Grace.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23401218      PMCID: PMC4460600          DOI: 10.1002/mds.25334

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  12 in total

Review 1.  Gating of information flow within the limbic system and the pathophysiology of schizophrenia.

Authors:  A A Grace
Journal:  Brain Res Brain Res Rev       Date:  2000-03

2.  Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

Authors:  R Swainson; R D Rogers; B J Sahakian; B A Summers; C E Polkey; T W Robbins
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

Review 3.  Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.

Authors:  Roshan Cools
Journal:  Neurosci Biobehav Rev       Date:  2005-06-01       Impact factor: 8.989

4.  Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.

Authors:  Alex A MacDonald; Oury Monchi; Ken N Seergobin; Hooman Ganjavi; Ruzbeh Tamjeedi; Penny A MacDonald
Journal:  Mov Disord       Date:  2012-11-19       Impact factor: 10.338

Review 5.  Functional magnetic resonance imaging of reward prediction.

Authors:  Brian Knutson; Jeffrey C Cooper
Journal:  Curr Opin Neurol       Date:  2005-08       Impact factor: 5.710

6.  Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.

Authors:  E D Abercrombie; A E Bonatz; M J Zigmond
Journal:  Brain Res       Date:  1990-08-13       Impact factor: 3.252

7.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.

Authors:  R Cools; R A Barker; B J Sahakian; T W Robbins
Journal:  Cereb Cortex       Date:  2001-12       Impact factor: 5.357

8.  Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey.

Authors:  W Schultz
Journal:  J Neurophysiol       Date:  1986-11       Impact factor: 2.714

9.  Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment.

Authors:  D G Harden; A A Grace
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

Review 10.  Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.

Authors:  Barry J Everitt; Trevor W Robbins
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.